CACCIATORE, Ivana
 Distribuzione geografica
Continente #
NA - Nord America 3.781
EU - Europa 3.707
AS - Asia 1.396
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 2
OC - Oceania 1
Totale 8.902
Nazione #
US - Stati Uniti d'America 3.769
IT - Italia 934
CN - Cina 724
IE - Irlanda 677
UA - Ucraina 539
SE - Svezia 486
TR - Turchia 397
GB - Regno Unito 370
FR - Francia 317
IN - India 192
DE - Germania 188
FI - Finlandia 99
VN - Vietnam 43
BE - Belgio 19
AT - Austria 17
HK - Hong Kong 16
GR - Grecia 15
IR - Iran 12
PL - Polonia 11
CA - Canada 9
RU - Federazione Russa 9
EU - Europa 7
CH - Svizzera 5
NL - Olanda 4
PK - Pakistan 4
AR - Argentina 3
CL - Cile 3
ES - Italia 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
CZ - Repubblica Ceca 2
IL - Israele 2
KR - Corea 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
DK - Danimarca 1
EG - Egitto 1
HU - Ungheria 1
ID - Indonesia 1
JP - Giappone 1
ME - Montenegro 1
MT - Malta 1
MX - Messico 1
RO - Romania 1
SM - San Marino 1
ZA - Sudafrica 1
Totale 8.902
Città #
Chandler 880
Dublin 669
Jacksonville 647
Southend 300
Princeton 272
Chieti 250
Izmir 218
Nanjing 192
Ashburn 166
Dearborn 151
Ann Arbor 147
Wilmington 122
Beijing 113
Cambridge 98
Altamura 94
New York 94
Nanchang 64
Boardman 60
Shenyang 50
Dong Ket 43
Kunming 39
Woodbridge 39
Tianjin 38
Pescara 35
Hebei 32
Rome 28
Jinan 27
Falls Church 26
Seattle 24
Washington 22
Jiaxing 21
Norwalk 21
Brussels 18
Grevenbroich 18
Zhengzhou 18
Kocaeli 17
Changsha 16
Los Angeles 16
Milan 16
Vienna 16
Augusta 14
Guangzhou 13
Leawood 13
Ningbo 13
Silvi 13
Teramo 13
Hangzhou 12
Hong Kong 12
Houston 11
Kraków 10
Lanzhou 10
San Mateo 10
Bologna 9
Changchun 9
Santa Maria Imbaro 8
Ardabil 7
Haikou 7
Helsinki 7
Lanciano 7
Pune 7
San Jose 7
Taizhou 7
Auburn Hills 6
Catania 6
Chicago 6
Edinburgh 6
Erzurum 6
Naples 6
Orange 6
Andover 5
Bonn 5
Florence 5
Hefei 5
L'aquila 5
Marche 5
Palermo 5
Perugia 5
Sacramento 5
Acquaviva Collecroce 4
Campomarino 4
Cepagatti 4
Circello 4
Collecorvino 4
Islamabad 4
Kowloon 4
L’Aquila 4
Monmouth Junction 4
Redwood City 4
Shanghai 4
Toronto 4
Ancona 3
Brescia 3
Clearwater 3
Ferrara 3
Frankfurt am Main 3
Fuzhou 3
Miami 3
Montesilvano 3
Mumbai 3
Orsogna 3
Totale 5.501
Nome #
Il cofarmaco ibuprofene-glutatione quale nuovo potenziale agente anti-alzheimer 195
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 122
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 117
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 116
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 113
Carvacrol reduces adipogenic differentiation by modulating autophagy and ChREBP expression 111
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases 109
Modulation of apoptotic cell death and neuroprotective effects of glutathione—L-Dopa codrug against H2O2-induced cellular toxicity 106
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 104
NSAID Coniugates for the treatment of Alzheimer's Disease 104
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 99
Synthesis of a novel TRH-related sulphonamido peptide 99
(R)-α-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease 98
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 96
Sintesi di trans-2-ammino-5(o 6)-cloro-6(o 5)-idrossi-1-fenil-2,3-diidro-1H-indani quali precursori di derivati a potenziale affinità per i recettori della dopamina 93
Cofarmaci L-Dopa-antiossidanti solforati quali nuovi potenziali agenti anti-Parkinson 93
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 93
Carvacrol prodrugs as novel antimicrobial agents 90
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 89
Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress 89
2,5-Diketopiperazines as neuroprotective agents 88
Synthesis of Short Cationic Antimicrobial Peptidomimetics Containing Arginine Analogs 88
Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro 88
N-(tert-butilossicarbonil)-beta,beta-ciclopentil-cisteina (acetamidometil)-metil estere per la sintesi di nuovi derivati peptidomimetici 87
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 85
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 85
L-dopa co-drugs in nanostructured lipid carriers: A comparative study 85
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 84
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 83
Carvacrol codrugs: A new approach in the antimicrobial plan 83
Synthesis and antioxidant properties of novel memantine derivatives 83
(R)-alpha-Lipoic Acid–Gly-L-Pro-L-Glu(OMe)-OMe Codrug as Multifunctional Agent for Neurodegenerative Diseases, with Antioxidant and Neuroprotective Properties 82
Carvacrol and its derivatives as antibacterial agents 82
Synthesis and activity of fluorescent glutathione S-conjugates as novel GST inhibitors 81
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 81
sintesi ed attività di due analoghi del glutatione a conformazione ristretta 81
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 81
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents 81
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 80
N-(tert)-Butyloxycarbonyl-beta,beta-Cyclopentyl-Cysteine (Acetamidomethyl)-Methyl Ester for Synthesis of Novel Peptidomimetic Derivatives 79
GPE and GPE analogues as promising neuroprotective agents 79
Effect of MRJF4 on C6 glioma cells proliferation and migration 79
Direct- and spacer-coupled codrug strategies for the treatment of Alzheimer’s disease 78
N-Acetyl-L-Methionyl-L-Dopa-Methyl Ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity 78
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma 78
Advances in prodrug design for Parkinson's disease 78
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 77
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 77
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 76
A Potent (R)-alpha-bis-lipoyl Derivative Containing 8-Hydroxyquinoline Scaffold: Synthesis and Biological Evaluation of Its Neuroprotective Capabilities in SH-SY5Y Human Neuroblastoma Cells 76
Role of Dietary Supplements in the Management of Parkinson's Disease 76
Transition state isosteres of the gamma-glutamyl peptide bond hydrolysis: synthesis and characterization of the psi (CH2NH) pseudopeptide analogue of glutathione 76
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 75
New pharmacologic tools against Parkinson's disease: L-Dopa-antioxidant codrugs containing the methionine residue 74
RNAIII Inhibiting Peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections 74
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 73
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 72
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 72
Synthesis and evaluation of new endomorphoin analogues modified at the Pro2 residue 72
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 72
Conformationally Constrained Histidines in the Design of Peptidomimetics: Strategies for the χ-Space Control 71
Synthesis of GPE analogues as potential neuroprotective agents 71
Delivery Methods of Camptothecin and Its Hydrosoluble Analogue Irinotecan for Treatment of Colorectal Cancer 70
MRJF4, a novel histone deacetylase inhibitor, induces p21 mediated autophagy in PC3 prostate cancer cells 70
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 69
Synthesis and activity of novel glutathione analogues containing an urethane backbone linkage 69
Molecular mechanism undelying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a Parkinson's animal model 69
Facile transformation of glutamic acid into proline residue inside a tripeptide backbone 68
Prodrug approach for increasing cellular glutathione levels 68
Natural oxyprenylated coumarins are modulators of melanogenesis 68
Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate 68
Biochemical properties of new synthetic carnosine analogues containing the residue of 2,3-diaminopropionic acid: the effect of N-acetylation 67
Synthesis and biological evaluation of the disulfide form of the glutathione analogue gamma-(L-glutamyl)-L-cysteinyl-L-aspartyl-L-cysteine. 67
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands 67
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 66
Synthesis and biological activity of new inhibitors of pantetheine hydrolase 66
Proline-Glutamate Chimeras in Isopeptides. Synthesis and Biological Evaluation of Conformationally Restricted Glutathione Analogues 65
A new chromogenic substrate for pantetheine hydrolase and vanin proteins 65
Chimica Farmaceutica 65
Recent tools to overcome antibacterial resistance 65
Cyclo(His-Pro) inhibits NLRP3 inflammasome cascade in ALS microglial cells 65
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases 65
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation 64
Cytotoxicity and genotoxicity of iron oxide nanoparticles: An in vitro biosafety study 64
Cyclo(His-Pro) exerts anti-inflammatory effects by modulating NF-kB and Nrf2 signalling 63
Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems. 63
Discovery of novel RIP derivatives by alanine scanning for the treatment of S. aureus infections. 63
synthesis and Activity of Endomorphin-1 and 2 analogues Incorporating Azetidine-(S)-2-carboxylic acid and Azetidine-3-carboxylic acid in place of native proline 62
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 62
Design, synthesis and evaluation of new endomorphin analogues incorporating constrained aminoacids in place of Pro2 residue 61
Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2 61
Discovery of Small Molecule Vanin Inhibitors: New Tools To Study Metabolism and Disease 61
Cyclo(His-Pro) promotes cytoprotection by activating Nrf2-mediated up-regulation of antioxidant defence 60
Hepatic effects of yttrium oxide nanoflowers: in vitro risk evaluation 60
Structure-Activity relationships of biphalin analogs and their biological evaluation on opioid receptors 60
Dimeric L-dopa derivatives as potential prodrugs. 59
Synthesis and biological evaluation of oligopeptides with antioxidant activity useful for treatment of neurodegenerative diseases 59
Neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo(His-Pro) to prevent LPS neurotoxicity 59
New L-Dopa codrugs as potential antiparkinson agents 59
Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation 59
Totale 7.898
Categoria #
all - tutte 30.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.375


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019291 0 0 0 0 0 0 0 0 0 0 14 277
2019/20201.762 483 100 22 42 133 154 272 146 49 176 155 30
2020/2021874 117 4 131 24 55 146 19 25 90 108 72 83
2021/2022749 32 22 10 74 88 33 36 50 103 33 70 198
2022/20232.378 177 358 155 258 212 451 114 216 281 47 54 55
2023/20241.139 97 66 72 47 63 409 273 70 20 22 0 0
Totale 9.314